Showing results (941-950 of 981) with videos related to
Sort By:
Pageof 99
Cancer Research|March 22, 2012
AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancerYon Hui Kim, Han Liang, Xiuping Liu, et al.Endocrine-Related Cancer|February 1, 2014
Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrenceWon-Mook Choi, Jeong-Hoon Lee, Jung-Hwan Yoon, et al.Cancer|January 20, 2017
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)Youjin Kim, Su Jin Lee, Ji Yun Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Gene expression signature-based prognostic risk score in gastric cancerJae Yong Cho, Jae Yun Lim, Jae Ho Cheong, et al.Journal of Gastric Cancer|July 7, 2017
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient DataCharles S Fuchs, Kei Muro, Jiri Tomasek, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2009
Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study GroupJi Eun Uhm, Byeong-Bae Park, Myung-Ju Ahn, et al.Scientific Reports|December 9, 2021
Impact of acute kidney injury on long-term adverse outcomes in obstructive uropathyJihyun Yang, Bong Gyun Sun, Hyeon-Jin Min, et al.Lancet (London, England)|January 10, 2012
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialYung-Jue Bang, Young-Woo Kim, Han-Kwang Yang, et al.Plos One|December 15, 2010
Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptomeSoo Mi Kim, Yun-Yong Park, Eun Sung Park, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer?Myung-Ju Ahn, Byeong-Bae Park, Jin Seok Ahn, et al.Pageof 99